| microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression P Dentelli, A Rosso, F Orso, C Olgasi, D Taverna, MF Brizzi Arteriosclerosis, thrombosis, and vascular biology 30 (8), 1562-1568, 2010 | 326 | 2010 |
| microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2C E Penna, F Orso, D Cimino, E Tenaglia, A Lembo, E Quaglino, L Poliseno, ... The EMBO journal 30 (10), 1990-2007, 2011 | 309 | 2011 |
| miR-214 as a key hub that controls cancer networks: small player, multiple functions E Penna, F Orso, D Taverna Journal of Investigative Dermatology 135 (4), 960-969, 2015 | 203 | 2015 |
| MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis BG Cuiffo, A Campagne, GW Bell, A Lembo, F Orso, EC Lien, MK Bhasin, ... Cell stem cell 15 (6), 762-774, 2014 | 199 | 2014 |
| miR148b is a major coordinator of breast cancer progression in a relapse‐associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1 D Cimino, C De Pittà, F Orso, M Zampini, S Casara, E Penna, E Quaglino, ... The FASEB Journal 27 (3), 1223-1235, 2013 | 159 | 2013 |
| miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation E Penna, F Orso, D Cimino, I Vercellino, E Grassi, E Quaglino, E Turco, ... Cancer research 73 (13), 4098-4111, 2013 | 107 | 2013 |
| PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p V Audrito, S Serra, A Stingi, F Orso, F Gaudino, C Bologna, F Neri, ... Oncotarget 8 (9), 15894, 2017 | 103 | 2017 |
| Role of miRNAs in tumor and endothelial cell interactions during tumor progression F Orso, L Quirico, D Dettori, R Coppo, F Virga, LC Ferreira, C Paoletti, ... Seminars in Cancer Biology 60, 214-224, 2020 | 96 | 2020 |
| AP‐2α and AP‐2γ regulate tumor progression via specific genetic programs F Orso, E Penna, D Cimino, E Astanina, F Maione, D Valdembri, ... The FASEB Journal 22 (8), 2702-2714, 2008 | 86 | 2008 |
| miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 M Arigoni, G Barutello, F Riccardo, E Ercole, D Cantarella, F Orso, L Conti, ... The American journal of pathology 182 (6), 2058-2070, 2013 | 83 | 2013 |
| miR-214 and miR-148b targeting inhibits dissemination of melanoma and breast cancer F Orso, L Quirico, F Virga, E Penna, D Dettori, D Cimino, R Coppo, ... Cancer research 76 (17), 5151-5162, 2016 | 76 | 2016 |
| 3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner PA Gagliardi, L di Blasio, F Orso, G Seano, R Sessa, D Taverna, ... Neoplasia 14 (8), 719-IN19, 2012 | 75 | 2012 |
| miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions EM Pinatel, F Orso, E Penna, D Cimino, AR Elia, P Circosta, P Dentelli, ... PLoS One 9 (1), e84859, 2014 | 69 | 2014 |
| The RNA-binding protein ESRP1 promotes human colorectal cancer progression S Fagoonee, G Picco, F Orso, A Arrigoni, DL Longo, M Forni, I Scarfò, ... Oncotarget 8 (6), 10007, 2017 | 65 | 2017 |
| miR-146a exerts differential effects on melanoma growth and metastatization M Raimo, F Orso, E Grassi, D Cimino, E Penna, C De Pittà, MB Stadler, ... Molecular Cancer Research 14 (6), 548-562, 2016 | 48 | 2016 |
| T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of … P Circosta, L Granziero, A Follenzi, E Vigna, S Stella, A Vallario, AR Elia, ... Human gene therapy 20 (12), 1576-1588, 2009 | 45 | 2009 |
| The role of melatonin on miRNAs modulation in triple-negative breast cancer cells LC Ferreira, F Orso, D Dettori, JZ Lacerda, TF Borin, D Taverna, ... PloS one 15 (2), e0228062, 2020 | 39 | 2020 |
| The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies L Quirico, F Orso Cancer Drug Resistance 3 (2), 117, 2020 | 39 | 2020 |
| Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5 … F Orso, E Cottone, MD Hasleton, JC Ibbitt, P Sismondi, HC Hurst, ... Biochemical Journal 377 (2), 429-438, 2004 | 39 | 2004 |
| VEGF blockade enhances the antitumor effect of BRAFV600E inhibition V Comunanza, D Corà, F Orso, FM Consonni, E Middonti, ... EMBO molecular medicine 9 (2), 219-237, 2017 | 38 | 2017 |
